# US 2025/0205404 A1 · System and method for automated assessment of peritoneal membrane function, residual cavity volume, and peritoneal adequacy

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0205404 A1
- Document ID: US20250205404A1
- Status: Published application
- Kind: A1
- Application number: 18/985,834
- Filed: 2024-12-18
- Published: 2025-06-26
- Earliest claimed: 2023-12-20
- Applicants: Fresenius Medical Care Holdings, Inc.; Fresenius Medical Care Deutschland GmbH
- Inventors: Paul Chamney; David Yuds; Eric Bergman; Kerissa Adams; Jun Yi
- Web page: https://patentgrep.com/patent/US20250205404A1

## CPC

- A61M 1/28: Peritoneal dialysis {; Other peritoneal treatment, e.g. oxygenation}
- A61M 1/282: {Operational modes}
- A61M 1/1609: {after use, i.e. downstream of dialyser}
- A61M 1/1619: {Sampled collection of used dialysate, i.e. obviating the need for recovery of whole dialysate quantity for post-dialysis analysis}
- G16H 10/60: for patient-specific data, e.g. for electronic patient records
- G16H 20/40: relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture
- G16H 40/67: for remote operation
- G16H 50/20: for computer-aided diagnosis, e.g. based on medical expert systems
- A61M 2202/0486: Glucose
- A61M 2205/3379: Masses, volumes, levels of fluids in reservoirs, flow rates
- A61M 2205/50: with microprocessors or computers
- A61M 2230/20: Blood composition characteristics
- A61M 2230/201: Glucose concentration
- A61M: DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY (introducing media into or onto the bodies of animals A61D7/00; means for inserting tampons A61F13/26; devices for administering food or medicines orally A61J; containers for collecting, storing or administering blood or medical fluids A61J1/05); DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY (surgery A61B; chemical aspects of surgical articles A61L); DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR {(Electrotherapy, e.g. producing anaesthesia by the use of alternating or intermittent currents A61N1/36021)}
- G16H: HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA

## Abstract

This disclosure teaches methods and systems for determining membrane transport parameters of a peritoneal dialysis (PD) patient, and updating a (PD) prescription of the patient based on one or more of the membrane transport parameters. The methods include withdrawing a plurality of samples of PD effluent from the patient's peritoneal cavity periodically during one or more dwell phases of one or more PD treatment cycles. The method further includes obtaining sensor measurements of the samples of PD effluent, determining one or more peritoneal membrane transport parameters based on the sensor measurements, and updating the patient's PD prescription, to be used for a later peritoneal dialysis treatment, based on the one or more peritoneal membrane transport parameters.

## Claims

### Claim 1

A method of updating a peritoneal dialysis (PD) prescription of a patient, comprising:
withdrawing a plurality of samples of peritoneal dialysis effluent from the patient's peritoneal cavity periodically during one or more dwell phases of one or more peritoneal dialysis treatment cycles;
obtaining sensor measurements of the samples of peritoneal dialysis effluent;
determining one or more peritoneal membrane transport parameters based on the sensor measurements; and
updating an individualized peritoneal dialysis prescription for the patient, to be used for a later peritoneal dialysis treatment, based on the one or more peritoneal membrane transport parameters.

### Claim 2 (depends on 1)

The method of claim 1, further comprising:
performing the later peritoneal dialysis treatment for the patient using the updated individualized peritoneal dialysis prescription.

### Claim 3 (depends on 1)

The method of claim 1, wherein withdrawing the plurality of samples comprises withdrawing the plurality of samples during a plurality of different dwell phases of the peritoneal dialysis treatment, and
wherein at least one of a dwell duration and a glucose concentration is different for the plurality of different dwell phases.

### Claim 4 (depends on 1)

The method of claim 1, wherein the sensor measurements of the samples of the peritoneal dialysis effluent indicate one or more glucose concentrations and one or more conductivity levels of one or more electrolyte concentrations of the samples of the peritoneal dialysis effluent.

### Claim 5 (depends on 4)

The method of claim 4, wherein the one or more peritoneal membrane transport parameters comprise a glucose transport constant, and wherein determining the glucose transport constant comprises:
performing an optimization procedure that fits a volume model for a peritoneal cavity fluid volume to the glucose concentrations from the sensor measurements of the samples of peritoneal dialysis effluent.

### Claim 6 (depends on 5)

The method of claim 5, wherein the volume model is either a fixed volume model represented by the following equation:
R
G
⁢
l
⁢
u
D
/
D
⁢
0
(
t
)
=
C
d
C
d
(
0
)
=
C
b
C
d
(
0
)
-
(
C
b
C
d
(
0
)
-
C
d
(
0
)
C
d
(
0
)
)
⁢
e
-
t
τ
G
⁢
l
⁢
u
=
C
b
C
d
(
0
)
+
(
1
-
C
b
C
d
(
0
)
)
⁢
e
-
t
τ
G
⁢
l
⁢
u
;
or the volume model is a variable volume represented by the following equation:
R
G
⁢
l
⁢
u
D
/
D
⁢
0
(
t
)
=
C
b
C
d
(
0
)
+
V
Tot
PC
(
0
)
V
Tot
PC
(
t
)
⁢
(
1
-
C
b
C
d
(
0
)
)
⁢
e
-
t
τ
glu
;
wherein RGluD/D0(t) is the temporal variation of glucose in PD effluent during the dwell phase, Cb is the concentration of glucose in blood, Cd is the concentration of glucose in the PD fluid contained in the peritoneal cavity, τGlu is the glucose transport constant, and VTotPC is the total volume of fluid in the peritoneal cavity.

### Claim 7 (depends on 5)

The method of claim 5, wherein the one or more peritoneal membrane transport parameters comprise a creatine rate constant (τCreat) and a urea rate constant (τUrea), which are determined based on the glucose transport constant and universal constants relating the glucose rate constant to the creatine and urea rate constant.

### Claim 8 (depends on 4)

The method of claim 4, wherein the one or more peritoneal membrane transport parameters comprise a rate of fluid absorption from the peritoneal cavity (Jv_Abs) and product of an average reflection coefficient (σAv) and an ultrafiltration (UF) coefficient (kUF), and wherein determining Jv_Abs, and the product of σAv and kUF, comprises:
determining a glucose transport constant by performing an optimization procedure that fits a volume model for peritoneal cavity fluid volume to the glucose concentrations from the sensor measurements of the samples of peritoneal dialysis effluent;
obtaining UF volumes for the dwell phases where the sensor measurements of the samples of PD effluent are obtained; and
determining Jv_Abs and a product of σAv and kUF based on the glucose transport constant, the UF volumes, and the glucose concentrations from the sensor measurements.

### Claim 9 (depends on 8)

The method of claim 8, wherein Jv_Abs and the product of σAv and kUF are determined utilizing the following equation:
V
Tot
P
⁢
C
(
t
)
=
V
fill
+
τ
g
⁢
l
⁢
u
·
k
UF
·
σ
A
⁢
v
·
Δ
⁢
P
Osm
(
0
)
·
(
1
-
e
-
t
τ
g
⁢
l
⁢
u
)
-
J
v
⁢
_
⁢
Abs
·
t
;
wherein VTotPC is a total volume of fluid in the peritoneal cavity, Vfill is a volume of PD fluid supplied during the fill phase, ΔPosm(0) is an initial transperitoneal differential osmotic pressure, and t is time.

### Claim 10 (depends on 1)

The method of claim 1, wherein withdrawing the plurality of samples of the peritoneal dialysis effluent from the patient's peritoneal cavity comprises:
providing, by a computing device and to a pump of a peritoneal dialysis system, first instructions to withdraw the plurality of samples; and
subsequent to providing the first instructions, providing, by the computing device, second instructions to fill the patient's peritoneal cavity with fresh peritoneal dialysis effluent, and
wherein obtaining the sensor measurements comprises obtaining the sensor measurements by the computing device and in response to providing the first instructions to withdraw the plurality of samples.

### Claim 11 (depends on 1)

The method of claim 1, wherein the peritoneal dialysis system comprises one or more buffer zones in fluid communication with the pump, and wherein withdrawing the plurality of samples of the peritoneal dialysis effluent from the patient's peritoneal cavity comprises:
providing, by a computing device and to a pump of a peritoneal dialysis system, first instructions to withdraw the plurality of samples; and
subsequent to providing the first instructions, providing, by the computing device, second instructions to fill the patient's peritoneal cavity with effluent from the one or more buffer zones, and
wherein obtaining the sensor measurements comprises obtaining the sensor measurements by the computing device and in response to providing the first instructions to withdraw the plurality of samples.

### Claim 12 (depends on 1)

The method of claim 1, wherein the individualized peritoneal dialysis prescription indicates a PD fluid glucose concentration, a PD fluid volume, and a dwell time for the patient, and wherein updating the individualized peritoneal dialysis prescription for the patient comprises adjusting at least one of the PD fluid glucose concentration, the PD fluid volume, or the dwell time based on the one or more peritoneal membrane transport parameters.

### Claim 13 (depends on 12)

The method of claim 12, further comprising:
adjusting the at least one of the PD fluid glucose concentration, the PD fluid volume, or the dwell time based on using the one or more peritoneal membrane transport parameters and one or more peritoneal dialysis prescription machine learning (ML)—artificial intelligence (AI) algorithms to determine an adjustment to the PD fluid glucose concentration, the PD fluid volume, or the dwell time; and
using the one or more peritoneal membrane transport parameters and one or more peritoneal dialysis failure ML—AI algorithms to determine a predicted time period for a membrane of the patient's peritoneal cavity to fail.

### Claim 14

A peritoneal dialysis (PD) system, comprising:
a pump configured to be fluidly connected to a PD patient line, wherein the pump is configured to withdraw samples of PD effluent periodically during a dwell phase of a peritoneal treatment for a patient;
a PD sensor in fluid communication with the patient line and configured to take sensor measurements of PD effluent entering or exiting the PD patient line;
a computing device, programmed to perform a peritoneal dialysis treatment using an individualized peritoneal dialysis prescription, wherein the individualized peritoneal dialysis prescription indicates a PD fluid glucose concentration, a PD fluid volume, and a dwell time for the patient;
wherein the computing device is configured to:
calculate one or more peritoneal membrane transport parameters based on a plurality of sensor measurements;
update the individualized peritoneal dialysis prescription for the patient based on the one or more peritoneal membrane transport parameters; and
perform a subsequent peritoneal dialysis treatment for the patient using the updated individualized peritoneal dialysis prescription.

### Claim 15

A method of determining a residual cavity volume of a peritoneal dialysis (PD) patient, comprising:
measuring glucose of a PD effluent during a drain phase to obtained glucose concentration of a residual cavity fluid (CRes);
measuring glucose of a fresh PD fluid during a fill phase to obtain glucose concentration of the fresh PD fluid (CPDF);
measuring glucose of a mixture of the residual cavity fluid and the fresh PD fluid from the peritoneal cavity (CMix); and
determining the residual cavity volume based on a fill volume (Vfill), CRes, CPDF, and CMix.

### Claim 16 (depends on 15)

The method of claim 15, wherein determining the residual cavity volume (VRes) utilizes the following equation:
V
Res
=
V
fill
(
C
PDF
-
C
Mix
)
C
Mix
-
C
Res
.

### Claim 17 (depends on 15)

The method of claim 15, further comprising:
determining one or more membrane transport rate constants; and
determining a peritoneal clearance metric based on the one or more membrane transport rate constants and the determined residual cavity volume.

### Claim 18

A method of determining a peritoneal clearance metric indicating an adequacy of a of a peritoneal dialysis (PD) treatment for a patient, comprising:
obtaining one or more membrane transport constants τ(i);
obtaining a plurality of volumes associated with the PD treatment, wherein the plurality of volumes comprises a residual cavity volume VRes, a drain volume VDrain, and a fill volume Vfill; and
determining a peritoneal clearance metric based on the one or more membrane transport constants, the drain volume, and the fill volume.

### Claim 19 (depends on 18)

The method of claim 18, wherein the one or more membrane transport constants τ(i) comprises a creatine rate constant (τCreat), a urea rate constant (τUrea), and/or a glucose transport constant (τGlu).

### Claim 20 (depends on 18)

The method of claim 18, wherein determining the peritoneal clearance metric utilizes the following equation:
K
〈
i
〉
=
1
+
(
V
Res
V
Res
+
V
Fill
-
1
)
·
e
T
Dwell
/
τ
〈
i
〉
·
V
Drain
where K(i) is the peritoneal clearance metric and TDwell is a dwell time associated with the PD treatment.

### Claim 21 (depends on 18)

The method of claim 18, further comprising:
updating an individual peritoneal dialysis prescription for the patient based on the determined peritoneal clearance metric; and
using the updated individual peritoneal dialysis prescription for a subsequent PD treatment for the patient.
